As of April 1, 2026, Inovio Pharmaceuticals Inc. (INO) is trading at $1.76, marking a 1.15% gain on the day’s session so far. This analysis covers key technical levels, recent market context, and potential near-term price scenarios for the biotech stock, with no recent earnings data available for the firm as of the date of publication. INO has traded within a defined range in recent weeks, as investors weigh broader biotech sector sentiment alongside potential future company-specific catalysts.
INO Stock Poised for Growth: Key Support Holds
INO - Stock Analysis
4727 Comments
1741 Likes
1
Lashan
Influential Reader
2 hours ago
This sounds like advice I might ignore.
👍 180
Reply
2
Saket
Senior Contributor
5 hours ago
Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
👍 112
Reply
3
Arusha
Consistent User
1 day ago
I wish I didn’t rush into things.
👍 239
Reply
4
Dynastie
Returning User
1 day ago
I read this and now I trust nothing.
👍 57
Reply
5
Jeannelle
Returning User
2 days ago
I nodded aggressively while reading.
👍 21
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.